C83.5
Lymphoblastic (diffuse) lymphoma
Clinical Classification Guidelines
Inclusion Terms
- B-precursor lymphoma
- Lymphoblastic B-cell lymphoma
- Lymphoblastic lymphoma NOS
- Lymphoblastic T-cell lymphoma
- T-precursor lymphoma
Medical Intelligence & Overview
Lymphoblastic lymphoma is a type of aggressive non-Hodgkin lymphoma that originates from immature lymphocytes, which are a type of immune cell. It can develop in lymph nodes or other tissues and often requires prompt medical attention. The term encompasses various subtypes, including B-cell and T-cell lymphoblastic lymphomas, reflecting the specific type of lymphocyte involved.
Causes & Symptoms
Clinical Causes: Genetic mutations that affect lymphocyte development Previous exposure to radiation or certain chemotherapy treatments Inherited genetic factors or family history of lymphoma Immune system suppression due to other medical conditions or medications Infections, such as certain viruses, that may influence lymphoma development
Key Symptoms: Swelling or a painless lump in the neck, armpit, or groin Unexplained weight loss Fever that persists or occurs in episodes Night sweats Fatigue or weakness Feeling full or uncomfortable in the abdomen if lymph nodes in the abdominal area are enlarged Shortness of breath or cough if chest lymph nodes are affected
Diagnostic & Treatment
Diagnosis Path: Physical examination to check for swollen lymph nodes or other symptoms Blood tests to assess overall health and look for signs of lymphoma Biopsy of affected tissue (such as lymph node biopsy) to identify cancer cells Imaging studies like CT scans, PET scans, or MRI to determine the extent of the disease Bone marrow biopsy in some cases to see if the disease has spread
Treatment Protocols: Chemotherapy regimens designed specifically for aggressive lymphomas Targeted therapy, if specific genetic markers are identified Immunotherapy to help the immune system fight cancer cells Stem cell or bone marrow transplant may be considered in certain cases Supportive care, including antibiotics or blood transfusions, to manage side effects
Clinical Advice & FAQs
Billing Guidance
Is C83.5 a billable ICD-10 code?
Yes, C83.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.5?
Clinical documentation must specify the nature of Lymphoblastic (diffuse) lymphoma and any associated comorbidities for accurate reporting.
Cite this Clinical Reference